首页 › 基金 › BVF INC/IL › PYXS

BVF INC/IL 对 PYXS 的持仓历史

PYXIS ONCOLOGY INC · 医疗保健

BVF INC/IL 在 Q3 2026 的 13F 申报中披露持有 PYXS(PYXIS ONCOLOGY INC)11,826,140 股,市值约 US$27.6M,约占其申报组合的 0.91%,在其申报持仓中市值排名第 25 位。 BVF INC/IL 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)11.83M 股
申报持仓市值$27.55M
组合权重0.91%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

BVF INC/IL 对 PYXS 的持仓演变

BVF INC/IL 于 Q3 2026 首次披露 PYXS 持仓:11,826,140 股(约 US$27.6M)。

逐季持仓明细

季度股数金额变化
Q3 2026 11.83M $27.55M 新进

关于 PYXS 与 13F 数据

PYXS(PYXIS ONCOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 PYXS,申报仓位最大的包括:GordonMD Global Investments LP (US$36.2M), PFIZER INC (US$20.1M), Laurion Capital Management LP (US$11.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PYXS 的基金

查看 PYXS 的全部基金持有人 →

常见问题

How long has BVF INC/IL held PYXS?

BVF INC/IL has disclosed PYXS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is BVF INC/IL's current position in PYXS?

As of Q3 2026, BVF INC/IL holds 11.83M shares of PYXS (PYXIS ONCOLOGY INC), valued at $27.55M, representing 0.91% of its reported portfolio and ranking #25.

Has BVF INC/IL been buying or selling PYXS?

In the latest 13F filing (Q3 2026), BVF INC/IL newly opened its position in PYXS.

Which other funds hold PYXS?

Other major institutional holders of PYXS include GordonMD Global Investments LP, PFIZER INC, Laurion Capital Management LP, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.